Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ARCB
ARCB logo

ARCB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ArcBest Corp (ARCB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
84.870
1 Day change
-0.60%
52 Week Range
112.920
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ArcBest Corp (ARCB) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators suggest a bearish trend with oversold conditions, but there is no clear signal for a reversal. The company's recent financial performance shows significant declines in revenue, net income, and EPS, which raises concerns about its growth trajectory. While insider buying is a positive sign, the lack of recent positive news and the mixed analyst ratings do not provide a compelling case for immediate investment.

Technical Analysis

The stock is in a bearish trend with the MACD histogram at -2.304, indicating negative momentum. RSI at 16.951 suggests the stock is oversold. The moving averages are converging, and the stock is trading near its support level of 83.108, with resistance at 88.318. Overall, the technical indicators point to a weak price trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
6

Positive Catalysts

  • Insider buying has increased significantly by 284.68% over the last month, which could indicate confidence from management or insiders.

Neutral/Negative Catalysts

  • The company's financial performance in Q4 2025 was poor, with revenue down 2.89% YoY, net income down 127.95% YoY, and EPS down 129.27% YoY. Additionally, the regular market price dropped by 7.10%, reflecting negative sentiment.

Financial Performance

In Q4 2025, ArcBest reported a revenue decline to $972.7M (-2.89% YoY), a net income loss of -$8.1M (-127.95% YoY), and an EPS decline to -0.36 (-129.27% YoY). Gross margin also dropped to 80.83 (-2.30% YoY), indicating a challenging financial environment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Recent updates include Citi raising the price target to $107 with a Buy rating, while JPMorgan and BofA maintain Neutral ratings with price targets of $90 and $102, respectively. Jefferies raised its target to $125 with a Buy rating, citing the company's physical asset transportation network as a long-term strength. However, some analysts highlight weaker-than-expected volumes and yields in February 2026.

Wall Street analysts forecast ARCB stock price to rise
11 Analyst Rating
Wall Street analysts forecast ARCB stock price to rise
5 Buy
6 Hold
0 Sell
Moderate Buy
Current: 85.380
sliders
Low
81
Averages
95.82
High
120
Current: 85.380
sliders
Low
81
Averages
95.82
High
120
JPMorgan
Neutral
maintain
$81 -> $90
AI Analysis
2026-03-10
New
Reason
JPMorgan
Price Target
$81 -> $90
AI Analysis
2026-03-10
New
maintain
Neutral
Reason
JPMorgan raised the firm's price target on ArcBest to $90 from $81 and keeps a Neutral rating on the shares. The firm adjusted targets in the transpiration and logistics group as part of a mid-quarter update.
Citi
Buy
maintain
$105 -> $107
2026-03-09
New
Reason
Citi
Price Target
$105 -> $107
2026-03-09
New
maintain
Buy
Reason
Citi raised the firm's price target on ArcBest to $107 from $105 and keeps a Buy rating on the shares. The firm says the company's mid-Q1 results were mixed but show improving trends.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ARCB
Unlock Now

People Also Watch